Treatment of h. pylori associated gastroduodenal disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/02 (2006.01) A61K 39/106 (2006.01) A61K 39/108 (2006.01)

Patent

CA 2154063

A method for the treatment of Helicobacter infection preferably H. pylori infection in a mammalian host such as a human comprises administration to the infected host of an immunologically effective amount of one or more Helicobacter antigen(s), preferably in association with a mucosal adjuvant such as cholera toxin or E.coli heat labile toxin.

Un procédé pour le traitement de l'infection par l'Helicobacter, de préférence l'Helicobacter pylori chez un hôte mammifère tel que l'être humain, comprend l'administration à l'hôte infecté d'une quantité immunologiquement efficace d'un ou plusieurs antigène(s) Helicobacter, de préférence en association avec un adjuvant muqueux tel que la toxine du choléra ou la toxine E.coli thermolabile.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of h. pylori associated gastroduodenal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of h. pylori associated gastroduodenal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of h. pylori associated gastroduodenal disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1588552

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.